Literature DB >> 31097518

Early access to bedaquiline for extensively drug-resistant (XDR) and pre-XDR tuberculosis.

Irina Vasilyeva1, Andrei Mariandyshev2, Boris Kazennyy3, Edita Davidavičienė4, Nacer Lounis5, Sofia Keim6.   

Abstract

Entities:  

Year:  2019        PMID: 31097518     DOI: 10.1183/13993003.02208-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  1 in total

1.  Bedaquiline-based treatment for extensively drug-resistant tuberculosis in South Africa: A cost-effectiveness analysis.

Authors:  Ginenus Fekadu; Jiaqi Yao; Joyce H S You
Journal:  PLoS One       Date:  2022-08-05       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.